Sinopharm Tech Holdings (SEHK:8156) Balance Sheet Analysis 2001-2025

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Metric	2023	2024	LTM
Total Cash And Short-Term Investments	HK$2.64M	HK$6.946M	HK$12.881M
Net Receivables	HK$28.556M	HK$26.441M	HK$24.941M
Inventory	HK$3.537M	HK$13.481M	HK$3.517M
Prepaid Expenses And Other Current Assets	HK$3.048M	HK$2.165M	-
Other Current Assets	HK$287K	HK$100K	-
Total Current Assets	HK$38.068M	HK$49.133M	HK$41.339M
Property, Plant And Equipment	HK$3.882M	HK$2.603M	HK$2.021M
Goodwill And Intangible Assets	-	-	-
Long-Term Investments	HK$2.54M	-	-
Deferred Tax Assets	-	-	-
Other Noncurrent Assets	-	-	-
Total Noncurrent Assets	HK$6.422M	HK$2.603M	HK$2.021M
Other Assets	-	-	-
Total Assets	HK$44.49M	HK$51.736M	HK$43.36M

Metric	2023	2024	LTM
Total Payables	HK$32.494M	HK$23.103M	HK$22.784M
Accrued Expenses	HK$1.271M	HK$1.123M	-
Short-Term Debt	HK$71.933M	HK$26.679M	HK$30.703M
Current Portion Of Lease Obligations	HK$670K	-	-
Income Taxes Payable	HK$115K	-	-
Current Deferred Revenue	HK$2.63M	HK$3.148M	-
Other Current Liabilities	HK$140.438M	HK$14.323M	HK$9.103M
Total Current Liabilities	HK$249.436M	HK$68.376M	HK$62.59M
Long-Term Debt	HK$-0.653M	HK$-20.054M	HK$21.862M
Capital Lease Obligations	HK$1.323M	HK$20.054M	-
Noncurrent Deferred Revenue	-	-	-
Noncurrent Deferred Tax Liabilities	-	-	-
Other Noncurrent Liabilities	-	-	-
Total Noncurrent Liabilities	HK$0.653M	HK$20.054M	HK$21.862M
Other Liabilities	-	-	-
Total Liabilities	HK$250.089M	HK$88.43M	HK$84.452M

Metric	2023	2024	LTM
Treasury Stock	-	-	-
Preferred Stock	-	-	-
Common Stock	HK$57.404M	HK$7.921M	HK$7.921M
Retained Earnings	HK$-2.993B	HK$-2.938B	HK$-2.941B
Additional Paid-In Capital	HK$2.705B	HK$2.742B	HK$2.742B
Accumulated Other Comprehensive Income	HK$31.981M	HK$151.716M	HK$150.574M
Other Stockholders' Equity	-	-	-
Total Common Stockholders' Equity	HK$-199.48M	HK$-36.868M	HK$-41.153M
Minority Interest	HK$-6.119M	HK$0.174M	HK$0.061M
Total Equity	HK$-205.599M	HK$-36.694M	HK$-41.092M
Total Liabilities And Equity	HK$44.49M	HK$51.736M	HK$43.36M

Metric	2023	2024	LTM
Total Investments	HK$2.54M	-	-
Total Debt	HK$73.256M	HK$46.733M	HK$52.565M
Net Debt	HK$70.616M	HK$39.787M	HK$39.684M

Sinopharm Tech Holdings Balance Sheet

Balance Sheet Composition